Pfizer receives early clearance from US FTC for Metsera acquisition
MLex Summary: Pfizer has announced that it received early termination from US antitrust authorities for its proposed acquisition of obesity startup company Metsera. "The termination of the waiting period under the HSR...To view the full article, register now.
Already a subscriber? Click here to view full article